PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

PBD Biotech broadens patent for tuberculosis diagnostic

Africa-based trials for a blood test that detects the risk of disease progression are due to begin. PBD Biotech has received a grant for its patent application fo...
Continue Reading →
News

Merck delivers vital data on evobrutinib

Treatment is a BTK inhibitor and has demonstrated a sound safety and tolerability profile Merck has announced updated four-year safety and efficacy data for its r...
Continue Reading →
News

Sangamo’s ST-920 demonstrates evidence of clinical benefit

Phase 1/2 research shows that treatment could be very effective against Fabry disease Sangamo Therapeutics – a company focused on genomic medicine – has announced...
Continue Reading →
News

Michael J. Fox Foundation funding boost for Newel Health’s Soturi

The next phase of Newel Health’s digital therapeutics solution for Parkinson’s disease gains a vital grant. Newel Health has revealed the next stage of developmen...
Continue Reading →
News

CSL’s first gene therapy for haemophilia B approved

Boost for affected patients as HEMGENIX receives a green light from European Commission. CSL has revealed that the European Commission (EC) has granted conditiona...
Continue Reading →
News

Important milestone for Valneva’s chikungunya vaccine

VLA1553 is a single-dose, live-attenuated vaccine candidate targeting the highly dangerous chikungunya virus. Valneva – a company focused on global vaccines – has...
Continue Reading →
News

Pfizer update Lyme disease vaccine candidate

Research concerning candidate VLA15 has been discontinued across certain trial sites. Pfizer has decided to discontinue a significant percentage of participants i...
Continue Reading →
News

Small Pharma begins phase 1 mental health therapy trial

Small Pharma – a company focused on psychedelic-assisted therapies for mental health conditions –has confirmed that a first subject has been dosed in its phase 1 stu...
Continue Reading →
News

National Cancer Institute and Gritstone bio team up on vaccine

Neoantigen vaccine candidate, SLATE-KRAS has demonstrated early evidence of efficacy. Gritstone bio – a company focused on developing global vaccinations – has re...
Continue Reading →
News

AstraZeneca’s Evusheld not recommended for certain adults

Advice concerns the use of the COVID-19 vaccine when treating specific vulnerable individuals. The National Institute for Health and Care Excellence (NICE) has is...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026